San Francisco’s Quintessential Neighborhood Bar
Open 11:30 to 2 am Daily
10:00 am on NFL Sundays
Raquel Bennett, Psy.D.
Dr. Bennett is a Post-Doctoral Fellow in Clinical Psychology (PSB 94022544), working under the supervision of Dr. Bravo. Dr. Bennett primarily works with people who are experiencing severe depression, who are on the bipolar spectrum, or who are contemplating suicide. She has been studying the therapeutic properties of ketamine since she first encountered it in 2002. In addition to her clinical work, Dr. Bennett’s practice has evolved to include consultation services for medical professionals who wish to add ketamine services to their offices. She also lectures frequently about therapeutic ketamine. Dr. Bennett is the Founder of KRIYA Institute and the Organizer of the KRIYA Conferences.
Gary Bravo, M.D.
Dr. Bravo is a Psychiatrist (CA G53626) with a long-standing interest in community mental health. He served as the Medical Director for Sonoma County Behavioral Health for many years, and also worked as a Forensic Psychiatrist in the Sonoma County courts and jails. Dr. Bravo is also interested in the therapeutic effects of meditation and the study of altered states of consciousness.
Dr. Bravo and Dr. Bennett share an office in San Francisco where we work with patients who want psychotherapy and/or medication management and/or ketamine treatment. Please note that our clinical practice is currently full; we are not accepting new patients into our practice at this time.
For a list of other local providers who work with ketamine, please go to the Find a Provider page.
KRIYA Institute is devoted to understanding the therapeutic properties of ketamine (and related medicines). We provide clinical services directly to patients; we give presentations about therapeutic ketamine in a variety of settings; we offer consultation services to physicians and therapists; and we run the KRIYA Conferences, which is the first and largest conference in the world devoted to the use of ketamine. Our mission is to bring together the most rigorous Science and an appreciation of Spirit in the study of psychospiritual medicines such as ketamine.
We have experience in using ketamine to help patients with severe unipolar depression (major depression), bipolar depression, suicidal ideation, OCD, pain with depression, and a number of other difficulties. We also have an interest in the use of ketamine as an adjunct to psychotherapy for personal exploration.
We have worked with low dose ketamine following the NIMH protocol; we have worked with moderate dose ketamine to provide ketamine-faciliated psychotherapy; and we have worked with high dose ketamine to induce dissociative and mystical experiences. We also have an interest in using ultra low dose and ultra high dose ketamine. We have experience with most of the routes of ketamine administration: IV (infusion), IM (injection), nasal, oral, sublingual, and transdermal. We believe that there is not one right way to use ketamine… we think that different patients are best served by different treatment strategies. We also have some experience with ketamine derivatives and other NMDA antagonists.